Synovial hypertrophy, not elsewhere classified, unspecified site
ICD-10 M67.20 is a billable code used to indicate a diagnosis of synovial hypertrophy, not elsewhere classified, unspecified site.
Synovial hypertrophy refers to the abnormal enlargement of the synovial membrane, which lines the joints and tendon sheaths. This condition can arise from various underlying causes, including inflammatory processes, mechanical stress, or degenerative changes. Synovial hypertrophy is often associated with conditions such as rheumatoid arthritis, osteoarthritis, and tenosynovitis, where the synovial tissue becomes inflamed and thickened. Clinically, patients may present with joint swelling, pain, and reduced range of motion. The unspecified site designation indicates that the hypertrophy is not localized to a specific joint or tendon sheath, making it essential for clinicians to conduct thorough evaluations to determine the underlying cause. Treatment may involve corticosteroid injections, physical therapy, or surgical interventions, such as synovectomy, to alleviate symptoms and restore function. Accurate coding of synovial hypertrophy is crucial for proper management and reimbursement, as it reflects the complexity of the patient's condition and the need for targeted therapeutic approaches.
Detailed history of joint symptoms, physical examination findings, and imaging results.
Patients with chronic joint pain and swelling, particularly in the context of autoimmune diseases.
Ensure that all relevant comorbidities and treatment responses are documented to support the diagnosis.
Surgical notes, pre-operative assessments, and post-operative follow-ups.
Patients undergoing surgical interventions for synovial hypertrophy or related conditions.
Document the specific surgical procedures performed and any complications encountered.
Used when performing joint injections for symptomatic relief of synovial hypertrophy.
Document the indication for the procedure, the joint involved, and the volume of fluid aspirated or injected.
Orthopedic specialists should ensure that the procedure is linked to the diagnosis of synovial hypertrophy.
M67.20 is significant as it captures cases of synovial hypertrophy that do not fit into more specific categories, allowing for appropriate management and treatment planning.
